Special Issue
Targeting inflammatory pathways in prevention and treatment of cancer
Submission Deadline: 31 December 2020
Articles: 1
Special Issue Editor
Guest Editor
Sahdeo Prasad
Ph.D., Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
Expertise: 80 publications, 0 grants, Editor of 4
Amit Kumar Tyagi
Ph.D., UT MD Anderson Cancer Center, Houston, Texas, USA
Expertise: 50 publications, grants, Editor of 26
Amit K Srivastava
PhD, Ohio State University, Columbus, Ohio USA
Expertise: 40 publications, grants, Editor of 2
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $500. We normally offer a discount greater than 30% (APC: $350) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable.


Keywords
Cancer, Inflammatory Responses, Molecular Biology, Signaling, Therapeutics
Share This Special Issue
Published Papers (1 papers)
Open Access
Article

Volatile oil of Teucrium alopecurus sensitizes colon cancer cells to TRAIL-induced cell death

Fatma Guesmi, Sahdeo Prasad, Wiem Tahri, Imen Dridi, Manel Ben Ali, Amor Hedfi, Ismail A. Ismail, Ahmed Landoulsi
Frontiers in Bioscience-Scholar Volume 13 Issue 1, pp.1-13
DOI: 10.52586/S548 Published: 30 June 2021